Antigens for the selection of pan-variable number of tandem repeats motif-specific human antibodies against Mucin-1

Journal of Immunological Methods

Volumn 316, Issue 1-2, 2006, Pages 116-124

  Persson, Jonas ^a   Ohlin, Mats ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Antibody; Antibody library; Antigen; Peptide; Specificity; Tumour associated antigen

Indexed keywords

ANTIGEN; EPITOPE; MUCIN 1; RECOMBINANT ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CHO CELL; CONTROLLED STUDY; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TARGETING; PROTEIN VARIANT; VARIABLE NUMBER OF TANDEM REPEAT;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; ECHOCARDIOGRAPHY, DOPPLER, COLOR; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MINISATELLITE REPEATS; MUCIN-1; MUCINS; PEPTIDE LIBRARY; SEQUENCE ANALYSIS, DNA;

EID: 33750008165     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.08.009     Document Type: Article

References (19)

1. Andersson E., Henderikx P., Krambovitis E., Hoogenboom H.R., and Borrebaeck C.A.K. A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells. Cancer Immunol. Immunother. 47 (1999) 249
2. Apostolopoulos V., and McKenzie I.F. Cellular mucins: targets for immunotherapy. Crit. Rev. Immunol. 14 (1994) 293
3. Engelmann K., Baldus S.E., and Hanisch F.G. Identification and topology of variant sequences within individual repeat domains of the human epithelial tumor mucin MUC1. J. Biol. Chem. 276 (2001) 27764
4. Epenetos A.A., Hird V., Lambert H., Mason P., and Coulter C. Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy. Int. J. Gynecol. Cancer 10 (2000) 44
5. Fowler J.C., Teixeira A.S., Vinall L.E., and Swallow D.M. Hypervariability of the membrane-associated mucin and cancer marker MUC1. Hum. Genet. 113 (2003) 473
6. Franke F.E., Kraus S., Eiermann C., Pauls K., Lalani E.N., and Bergmann M. MUC1 in normal and impaired spermatogenesis. Mol. Hum. Reprod. 7 (2001) 505
7. Gendler S.J., Lancaster C.A., Taylor-Papadimitrou J., Duhig T., Peat N., Burchell J., Pemberton L., Lalani E.N., and Wilson D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265 (1990) 15286
8. Jirholt P., Ohlin M., Borrebaeck C.A.K., and Söderlind E. Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework. Gene 215 (1998) 471
9. Jirholt P., Strandberg L., Jansson B., Krambovitis E., Söderlind E., Borrebaeck C.A.K., Carlsson R., Danielsson L., and Ohlin M. A central core structure in an antibody variable domain determines antigen specificity. Protein Eng. 14 (2001) 67
10. Jirholt P., Borrebaeck C.A.K., and Ohlin M. Antibody evolution in vitro from the centre to the periphery-applied to a human antibody fragment recognising the tumour-associated antigen mucin-1. J. Mol. Biol. 318 (2002) 407
11. Krambovitis E., Hatzidakis G., and Barlos K. Preparation of MUC-1 oligomers using an improved convergent solid phase peptide synthesis. J. Biol. Chem. 273 (1998) 10874
12. Ladner R.C. Constrained peptides as binding entities. Trends Biotechnol. 13 (1995) 426
13. Lantto J., Lindroth Y., and Ohlin M. Non-germline encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus. Eur. J. Immunol. 32 (2002) 1659
14. Müller S., Alving K., Peter-Katalinic J., Zachara N., Gooley A.A., and Hanisch F. High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells. J. Biol. Chem. 274 (1999) 18165
15. Persson J., Lantto J., Drakenberg T., and Ohlin M. Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicity. Mol. Immunol. 42 (2005) 1321
16. Price M.R., Rye P.D., Petrakou E., Murray A., Brady K., Imai S., Haga S., Kiyozuka Y., Schol D., Meulenbroek M.F.A., Snijdewint F.G.M., von Mensdorff-Pouilly S., Verstraeten R.A., Kenemans P., Blockzjil A., Nilsson K., Nilsson O., Reddish M., Suresh M.R., Koganty R.R., Fortier S., Baronic L., Berg A., Longenecker M.B., Hilkens J., Boer M., Karanikas V., McKenzie I.F.C., Galanina O.E., Simeoni L.A., Ter-Grigoryan A.G., Belyanchikov I.M., Bovin N.V., Cao Y., Karsten U., Dai J., Allard W.J., Davis G., Yeung K.K., Hanish F.G., Lloyd K.O., Kudryashov V., Sikut R., Sikut A., Zhang K., Baeckström D., Hansson G.C., Reis C.A., Hassan H., Bennett E.P., Claussen H., Norum L., Varaas T., Kierulf B., Nustad K., Ciborowski P., Konitzki W.M., Magarian-Blader J., Finn O.J., and Hilgers J. Summary report on the ISOBM TD-4 workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol. 19 suppl. 1 (1998) 1
17. Söderlind E., Strandberg L., Jirholt P., Kobayashi N., Alexeiva V., Åberg A.M., Nilsson A., Jansson B., Ohlin M., Wingren C., Danielsson L., Carlsson R., and Borrebaeck C.A.K. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat. Biotechnol. 18 (2000) 852
18. von Mensdorff-Pouilly S., Kinarsky L., Engelmann K., Baldus S.E., Verheijen R.H., Hollingsworth M.A., Pisarev V., Sherman S., and Hanisch F.G. Sequence-variant repeats of MUC1 show higher conformational flexibility are less densely O-glycosylated and induce differential B lymphocyte responses. Glycobiology 15 (2005) 735
19. Xu J.L., and Davis M.M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13 (2000) 37